INmune Bio, Inc. (INMB) DCF Valuation

INmune Bio, Inc. (INMB) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

INmune Bio, Inc. (INMB) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment choices with the INmune Bio, Inc. (INMB) DCF Calculator! Explore accurate financial data for INmune Bio, adjust growth projections and expenses, and instantly observe how these alterations affect the intrinsic value of INmune Bio, Inc. (INMB).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 77.7 .0 .2 .4 .2 .2 .2 .2 .2 .3
Revenue Growth, % 0 -99.99 1558.12 106.63 -58.56 10.36 10.36 10.36 10.36 10.36
EBITDA .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
EBITDA, % 0 0 0 0 0 0 0 0 0 0
Depreciation 9.3 12.2 29.2 26.0 29.7 .1 .2 .2 .2 .2
Depreciation, % 11.97 112019.05 16106.63 6938.77 19187.74 82.39 82.39 82.39 82.39 82.39
EBIT -9.3 -12.2 -29.2 -26.0 -29.7 -.1 -.2 -.2 -.2 -.2
EBIT, % -11.97 -112019.05 -16106.63 -6938.77 -19187.74 -82.39 -82.39 -82.39 -82.39 -82.39
Total Cash 7.0 22.0 74.8 52.2 35.8 .1 .2 .2 .2 .2
Total Cash, percent .0 .2 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .6 1.8 5.5 8.5 2.4
Account Receivables, % 0.83071 16480.4 3040.88 2262.3 1575.48
Inventories -769.1 -2,018.6 -5.5 .0 .0 -.1 -.1 -.1 -.1 -.1
Inventories, % -990.02 -18492294 -3040.88 9.09 0 -58.18 -58.18 -58.18 -58.18 -58.18
Accounts Payable .4 1.5 3.8 5.2 7.9 .1 .2 .2 .2 .2
Accounts Payable, % 0.51744 13906.19 2101.1 1391.98 5097.42 80.1 80.1 80.1 80.1 80.1
Capital Expenditure .0 .0 -15.0 .0 .0 .0 .0 .0 .0 -.1
Capital Expenditure, % 0 0 -8287.29 0 0 -20 -20 -20 -20 -20
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -11.1 -12.2 -29.2 -27.2 -29.7 -.1 -.2 -.2 -.2 -.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 767.1 1,249.5 -2,029.5 -8.4 8.7 -5.4 .0 .0 .0 .0
WACC, % 12.22 12.22 12.22 12.22 12.22 12.22 12.22 12.22 12.22 12.22
PV UFCF
SUM PV UFCF -4.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -5
Net Debt -25
Equity Value 20
Diluted Shares Outstanding, MM 18
Equity Value Per Share 1.13

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: INmune Bio, Inc. (INMB)’s financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for testing projections, validating strategies, and enhancing efficiency.

Key Features

  • Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for INmune Bio, Inc. (INMB).
  • WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to INMB.
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as per INmune Bio's financial strategy.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to INmune Bio, Inc. (INMB).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of INMB.

How It Works

  1. Step 1: Download the Excel file for INmune Bio, Inc. (INMB).
  2. Step 2: Review INmune Bio’s pre-filled financial data and projections.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you modify your assumptions.
  5. Step 5: Evaluate the outputs and apply the results to inform your investment choices.

Why Choose This Calculator for INmune Bio, Inc. (INMB)?

  • Comprehensive Tool: Combines DCF, WACC, and financial ratio analyses tailored for INMB.
  • Customizable Inputs: Easily modify yellow-highlighted cells to explore different scenarios.
  • Detailed Insights: Automatically computes INmune Bio’s intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on INMB.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for analyzing INmune Bio, Inc. (INMB) investments.
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights to clients interested in INmune Bio, Inc. (INMB).
  • Students and Educators: Utilize real-time data for practicing and teaching financial modeling techniques.
  • Biotech Enthusiasts: Gain insights into how biotech companies like INmune Bio, Inc. (INMB) are appraised in the market.

What the Template Contains

  • Pre-Filled Data: Includes INmune Bio, Inc.'s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze INmune Bio, Inc.'s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.